ArticlePharmacoEconomics - open2020

Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast Counts.

D Coyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.